Skip to main content

US ClosedU.S. Closed

COCP: Cocrystal Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses.

52W Range

18thpctl

Volume

0.31×avg

Market Cap

15.17MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cocrystal Pharma, Inc.

COCPNASDAQ Capital Market·USD·Closed

Cocrystal Pharma, Inc.

COCPNASDAQ·USD·Closed

$1.10

−3.51%

$1.10

−$0.04 (3.51%)

52W Range

18thpctl

Volume

0.31×avg

Mkt Cap

15.17MUSD

P/E

-1.4TTM

Div Yield

–ann